Frec Markets’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$937K Sell
5,804
-367
-6% -$61.2K 0.06% 416
2026
Q2
$1.17M Buy
6,171
+910
+17% +$171K 0.11% 195
2026
Q1
$1.04M Buy
5,261
+1,206
+30% – 0.18% 99
2025
Q4
$746K Hold
4,055
– – 0.22% 83

Other funds holding AZN

Frec Markets's AZN Position: Q3 2026 in Review

Frec Markets reduced its AstraZeneca (AZN) stake by 5.9% in Q3 2026, selling an estimated $61.2K and leaving 5,804 shares worth $937K. The position accounts for 0.06% of the portfolio, ranked #416.

Frec Markets first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.17M in Q2 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Frec Markets held 5,804 shares of AstraZeneca worth $937K as of Q3 2026.
  • Frec Markets sold 367 AstraZeneca shares in Q3 2026, an estimated $61.2K.
  • AstraZeneca made up 0.06% of Frec Markets's portfolio in Q3 2026, its #416 holding.
  • Frec Markets first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • Frec Markets's AstraZeneca position peaked at $1.17M in Q2 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.